Europe

United Kingdom

Health authorities approved oral antiviral molnupiravir to treat mild-to-moderate Covid-19 in adults at risk for severe illness; it is the world's first oral antiviral to be authorized anywhere for the treatment of Covid-19


More lines about United Kingdom, Europe

Visit all United Kingdom lines archive